Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
- PMID: 29872302
- PMCID: PMC5973310
- DOI: 10.2147/NDT.S164307
Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
Abstract
Benzodiazepines are one of the most prescribed medications as first-line treatment of anxiety, insomnia, and epilepsy around the world. Over the past two decades, advances in the neuropharmacological understanding of gamma aminobutyric acid (GABA)A receptors revealed distinct contributions from each subtype and produced effects. Recent findings have highlighted the importance of α1 containing GABAA receptors in the mechanisms of addiction and tolerance in benzodiazepine treatments. This has shown promise in the development of tranquilizers with minimal side effects such as cognitive impairment, dependence, and tolerance. A valium-like drug without its side effects, as repeatedly demonstrated in animals, is achievable.
Keywords: GABAA receptor; anxiolytic; benzodiazepines; dependence; subtype; tolerance.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72(2):136–142. - PubMed
-
- Dantzer R. Behavioral effects of benzodiazepines: a review. Neurosci Biobehav Rev. 1977;1(2):71–86.
-
- Shader R, Greenblatt D, Balter M. Appropriate use and regulatory control of benzodiazepines. J Clin Pharmacol. 1991;31(9):781–784. - PubMed
-
- Sternbach L. The benzodiazepine story. J Med Chem. 1979;22(1):1–7. - PubMed
-
- Olsen R, Wamsley J, Lee R, Lomax P. Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy. Adv Neurol. 1986;44:365–378. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
